Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009

Thomas Weiss1, Dongmu Zhang1, Nagesh N Borse2

  • 1Center for Observational and Real-World Effectiveness, Merck & Co., Inc., Kenilworth, NJ, USA.

Vaccine
|August 12, 2015
PubMed

Insights

Many children still miss hepatitis A vaccination series initiation and completion. Identifying missed opportunities and ensuring timely vaccination is crucial for preventing this disease.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Public health

Background:

  • Hepatitis A remains a public health concern, necessitating high vaccination coverage.
  • Understanding vaccination patterns is key to improving public health outcomes.

Purpose of the Study:

  • To determine hepatitis A vaccine series initiation and completion rates in children.
  • To identify factors influencing vaccination timeliness and completion.
  • To pinpoint missed opportunities for hepatitis A vaccination.

Main Methods:

  • Retrospective, observational study utilizing three large healthcare claims databases.
  • Analysis of children born between 2005-2009, followed for 3.5 years post-birth.
  • Examination of vaccination records and healthcare utilization patterns.

Main Results:

  • Initiation rates ranged from 63.8-79.4%, with completion rates from 45.1-66.8% across databases.
  • A significant proportion of unvaccinated children had well visits, indicating missed opportunities.
  • Factors like birth year, state mandates, HMO enrollment, and provider type influenced vaccination success.

Conclusions:

  • Despite improvements, substantial gaps in hepatitis A vaccine coverage persist.
  • Vaccine coverage has plateaued in recent birth cohorts.
  • Proactive identification of vaccination opportunities by providers is essential to protect children.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
54.0K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
42
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
51
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
378
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
341
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K